Association of visual hallucinations with reduction of MIBG cardiac uptake in Parkinson's disease

Journal of the Neurological Sciences

Volumn 264, Issue 1-2, 2008, Pages 22-26

  Kitayama, Michio ^a   Wada Isoe, Kenji ^a   Irizawa, Yoshito ^a   Nakashima, Kenji ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

123I MIBG cardiac scintigraphy; Dementia; H M ratio; Psychiatric symptoms; Washout rate

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123;

ADULT; AGE DISTRIBUTION; AGED; ANALYSIS OF COVARIANCE; ARTICLE; DEMENTIA; DISEASE SEVERITY; FEMALE; HEART DENERVATION; HEART SCINTISCANNING; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPATHETIC INNERVATION; UNIVERSITY HOSPITAL; VISUAL HALLUCINATION;

3-IODOBENZYLGUANIDINE; AGE FACTORS; AGE OF ONSET; AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; AUTONOMIC NERVOUS SYSTEM DISEASES; COMORBIDITY; DOWN-REGULATION; FEMALE; HALLUCINATIONS; HEART; HEART CONDUCTION SYSTEM; HUMANS; IODINE RADIOISOTOPES; LEWY BODY DISEASE; MALE; MULTIVARIATE ANALYSIS; PARKINSON DISEASE; PREDICTIVE VALUE OF TESTS; RADIONUCLIDE IMAGING; SYMPATHETIC FIBERS, POSTGANGLIONIC;

EID: 36649003080     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.07.017     Document Type: Article

References (29)

1. Wieland D.M., Brown L.E., Rogers W.L., Worthington K.C., Wu J.L., Clinthorne N.H., et al. Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med 22 (1981) 22-31
2. Orimo S., Ozawa E., Nakade S., Sugimoto T., and Mizusawa H. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. J Neurol Neurosurg Psychiatry 67 (1999) 189-194
3. Yoshita M., Taki J., Yokoyama K., Noguchi-Shinohara M., Matsumoto Y., Nakajima K., et al. Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD. Neurology 66 (2006) 1850-1854
4. Orimo S., Amino T., Takahashi A., Kojo T., Uchihara T., Mori F., et al. Cardiac sympathetic denervation in Lewy body disease. Parkinsonism Relat Disord 12 Suppl 2 (2006) S99-S105
5. Nagayama H., Hamamoto M., Ueda M., Nagashima J., and Katayama Y. Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease. J Neurol Neurosurg Psychiatry 76 (2005) 249-251
6. Hamada K., Hirayama M., Watanabe H., Kobayashi R., Ito H., Ieda T., et al. Onset age and severity of motor impairment are associated with reduction of myocardial 123I-MIBG uptake in Parkinson's disease. J Neurol Neurosurg Psychiatry 74 (2003) 423-426
7. Saiki S., Hirose G., Sakai K., Kataoka S., Hori A., Saiki M., et al. Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD. J Neurol Sci 220 (2004) 105-111
8. Hughes A.J., Daniel S.E., Kilford L., and Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55 (1992) 181-184
9. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. fourth edition (1994), American Psychiatric Association, Washington DC, USA 133-155
10. Poewe W. Psychosis in Parkinson's disease. Mov Disord 18 (2003) S80-S87
11. Williams D.R., and Lees A.J. Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study. Lancet Neurol 4 (2005) 605-610
12. Diederich N.J., Goetz C.G., and Stebbins G.T. Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: focused review and a new integrative model. Mov Disord 20 (2005) 130-140
13. Fenelon G., Goetz C.G., and Karenberg A. Hallucinations in Parkinson disease in the prelevodopa era. Neurology 66 (2006) 93-98
14. Pacchetti C., Manni R., Zangaglia R., et al. Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease. Mov Disord 20 (2005) 1439-1448
15. Papapetropoulos S., Argyriou A., and Ellul J. Factors associated with drug-induced visual hallucinations in Parkinson's disease. J Neurol 252 (2005) 1223-1228
16. Hietanen M., and Teravainen H. The effect of age of disease onset on neuropsychological performance in Parkinson's disease. J Neurol Neurosurg Psychiatry 51 (1988) 244-249
17. Martin W.E., Loewenson R.B., and Resch J.A. Parkinson's disease. Clinical analysis of 100 patients. Neurology 23 (1973) 783-790
18. Aarsland D., Zaccai J., and Brayne C.A. Systematic review of prevalence studies of dementia in Parkinson's disease. Mov Disord 20 (2005) 1255-1263
19. Aarsland D., Larsen J.P., Cummins J.L., et al. Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. Arch Neurol 56 (1999) 595-601
20. Fenelon G., Mahieux F., Huon R., et al. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain 123 (2000) 733-745
21. Holroyd S., Currie L., and Wooten G.F. Prospective study of hallucinations and delusions in Parkinson's disease. J Neurol Neurosurg Psychiatry 70 (2001) 734-738
22. 123I-metaiodobenzylguanidine. Diabetes 41 (1992) 1069-1075
23. Stanton M.S., Tuli M.M., Radtke N.L., et al. Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123 metaiodobenzylguanidine. J Am Coll Cardiol 14 (1989) 1519-1526
24. Sisson J.C., Shapiro B., Meyers L., et al. Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med 28 (1987) 1625-1636
25. Takatsu H., Nishida H., Matsuo H., Watanabe S., Nagashima K., Wada H., et al. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG. J Nucl Med 41 (2000) 71-77
26. Taki J., Nakajima K., Hwang E.H., Matsunari I., Komai K., Yoshita M., et al. Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. Eur J Nucl Med 27 (2000) 566-573
27. Kitayama M. Wada-Isoe K, Nakaso K, Irizawa Y, Nakashima, K. Clinical evaluation of Parkinson's diseasae dementia: association with aging and visual hallucination. Acta Scand Neurol (in press), doi:10.1111/j.16660-0404.2007.00860.x.
28. 123I] metaiodobenzylguanidine-SPECT. Brain 124 (2001) 2372-2382
29. Lee P.H., Yeo S.H., Kim H.J., and Youm H.Y. Correlation between cardiac 123I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy. Mov Disord 21 (2006) 1975-1977